ClinicalTrials.govpublic full text
Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease
alzheimer's disease, dementia, memory loss, cognitive impairment, nerve growth factor, ngf, neurotrophic factors, gene therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 910382
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.